J&J Halts Development of Epilepsy Therapy ADX71149 After Phase II Trial Failure
Johnson & Johnson (J&J; NYSE: JNJ), a US-based multinational medical devices, pharmaceutical, and consumer packaged...
Abbott Laboratories Reports Q2 2024 Sales Growth of 9.3%, Led by Medical Devices and Diabetes Sales
Abbott Laboratories (NYSE: ABT), a global healthcare giant based in the US, has reported its...
Sino Biopharmaceutical Submits Market Approval Filing for CDK2/4/6 Inhibitor Culmerciclib in Breast Cancer
Sino Biopharmaceutical Ltd (HKG: 1177), a leading biopharmaceutical company in China, has announced the submission...
Eli Lilly’s Mounjaro Approved by China’s NMPA for Long-Term Weight Management
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company in the US, has announced...
China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome...
China’s NMPA Suspends Daewoong Bio’s Cefodizime Over Inspection Refusal
The National Medical Products Administration (NMPA) has issued a notice to suspend the import, sale,...
Bain Capital-Backed Tenacia Wins NMPA Approval for Ganaxolone Oral Suspension for CDKL5 Deficiency
Tenacia, a central nervous system (CNS) specialist company incubated by Bain Capital, has announced that...
MicroPort MedTech’s Vepack Filter Retriever Earns NMPA Marketing Approval
Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016), a prominent medical device company based in...
Venus Medtech’s VenusP-Valve Receives Marketing Approval in Venezuela, Expanding Global Reach
Venus Medtech (Hangzhou) Inc., (HKG: 2500), a leading medical device company, has announced that it...
Anhui Anke Biotechnology Receives NMPA Clearance for Clinical Trial of mRNA Drug AFN0328 for HPV-Related Cancers
Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009), a biopharmaceutical company based in China, has...
Shanghai Sanyou Medical’s Cervical Thoracic Internal Fixation System Earns NMPA Approval
Shanghai Sanyou Medical Co., Ltd (SHA: 688085), a leading medical device company based in China,...
Suzhou New District Hi-tech Industrial Co., Ltd and Subsidiaries to Establish Biopharmaceutical FOF with SND Group
Suzhou New District Hi-tech Industrial Co., Ltd (SHA: 600736), a prominent company in China’s high-tech...
NeuShen Therapeutics and Livzon Pharma Strike Deal for Greater China Rights to NS-041
NeuShen Therapeutics, a Sino-US biopharmaceutical company, has entered into a licensing agreement with Livzon Pharmaceutical...
NHSA Mandates Standardized Online Procurement for Injectable Drugs to Ensure Pricing Transparency
The National Healthcare Security Administration (NHSA) has issued a directive to standardize the procurement process...
Consun Pharmaceutical Gets NMPA Go-Ahead for CKD Drug Clinical Trial
Consun Pharmaceutical Group Ltd (HKG: 1681), a leading Chinese pharmaceutical company, has announced that it...
Shanghai Ruijin Hospital’s Hainan Subsidiary Adopts ANI Pharmaceuticals’ Veregen for HPV Treatment
ANI Pharmaceuticals’ Veregen, a topical ointment derived from green tea extract (catechins), has been implemented...
Roche’s Genentech Terminates Relay Therapeutics Collaboration for SHP2 Inhibitor
In a recent development, Roche Inc.’s subsidiary Genentech has given notice of termination for a...
Johnson & Johnson Reports Robust Q2 2024 Earnings, Bolstered by Pharma and Medtech Growth
Johnson & Johnson (NYSE: JNJ) has reported its financial results for the second quarter of...
Shanghai Escugen and Sidewinder Therapeutics Form Strategic Alliance for ADC Development
Shanghai Escugen, a leading biopharmaceutical company specializing in antibody drug conjugates (ADCs), has announced a...
Junshi Biosciences’ Loqtorzi Inches Closer to Expanded Indication with NMPA Filing Acceptance
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has taken a significant step forward...